Related Content
Download content relating to this event and topic.
Antibody Engineering Europe 2027
2nd Edition
WHERE NEXT GENERATION DESIGN MEETS REAL-WORLD THERAPEUTIC DEVELOPMENT
Antibody Engineering Europe 2027 brings together discovery scientists, translational researchers, and platform innovators working to design the next wave of antibody therapeutics. From multispecific formats to AI-enabled discovery and developability optimisation, this is where engineering strategies move from concept to clinical reality.
Dublin
24
February
-
25
February
2027
00
Days
00
Hours
00
Mins
00
Secs
+
Attendees
200
Maximum Attendees
100
+
Companies
60
+
Speakers
+
Networking Hours
+
Case Studies
6
Interactive Sessions
About the Event
Monoclonal antibodies remain one of the most powerful and versatile therapeutic modalities in modern medicine. Yet as pipelines expand into bispecifics, multispecific antibodies, antibody fragments, and novel immune-engaging platforms, the complexity of antibody design continues to grow. Antibody Engineering Europe 2027 convenes leading biopharma teams, scientists and technical leaders engineering next-generation antibody modalities including bispecifics, multispecifics, and immune-engaging platforms. Those responsible for transforming antibody concepts into viable therapeutic candidates. Across discovery, engineering, and early development, the event focuses on how teams are improving binding specificity, stability, manufacturability, and clinical performance.
Rather than purely academic discussions, this forum focuses on the practical challenges facing antibody programmes today - from developability risk and platform optimisation to the successful translation of discovery breakthroughs into therapeutic candidates. Attendees will discover how AI and advanced screening technologies are advancing antibody discovery, explore strategies to improve developability and manufacturability, benchmark leading engineering platforms, and engage with the experts driving the next generation of antibody therapeutics.
Co-Located Events
Visit the event page to view more content.
Awards Cerermony
Visit the awards page to view more content.
Agenda at a Glance
View the Key Themes for
Antibody Engineering & ADC Manufacturing Europe 2027
Next-Generation Antibody Formats
- Bispecific and multispecific antibodyengineering
- Novel immune-engaging platforms and scaffolds
- AI-designed antibody formats and modular design
AI-Driven Discovery and Screening
- AI and ML in drug design and optimisation
- High-throughput screening and computational modelling
- Accelerating antibody identification and optimisation
Developability and Manufacturability
- Designing for manufacturability from discovery
- Reducing cost per gram and expanding production
- Bringing complex antibodies to GMP reality
Clinical Translation and Insights
- Lessons from Europe's leading clinical trials
- Translating discovery breakthroughs into scalable pipelines
- Democratising access and reducing development cost
Smart Manufacturing and Future Outlook
- Process intensification and automation
- Smart factories and predictive controls
- 2035 outlook for antibody manufacturing
Ready to attend?
Register today to secure your ticket.
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Advisory Board Commitee
Chairman
Timmy Carey
Director of Global Environmental Sustainability
BioMarin
Ireland
Declan Lowney
johnson & Johnson
Director of Stability Sciences, BioTherapeutics Development Analytical Development
Ireland
Connect on LinkedInAdvisory Board Commitee
Chairman
Declan Lowney
Director of Stability Sciences, BioTherapeutics Development Analytical Development
johnson & Johnson
Ireland
Advisory Board Commitee
Chairman
Miriam O'Sullivan
Executive Director Plant Manager
Amgen
Ireland
Advisory Board Commitee
Chairman
Cian O'Brien
Site Head
Sanofi
Ireland
Want to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Apply to SpeakPrincipal
No items found.
Platinum
No items found.
Gold
Silver
No items found.
Bronze
No items found.
Exhibition & Showcase
.webp)
Associate
Media & Publicity
No items found.
Trusted by Industry Leaders
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
Merck
Field Marketing Manager, United Kingdom
"Really well organised conference with great attendees and high engagement - I was delighted to have taken the time to attend and really enjoyed sharing my thoughts."
BMS
Director, Manufacturing Technology, Ireland
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
Merck
Field Marketing Manager, United Kingdom
"Really well organised conference with great attendees and high engagement - I was delighted to have taken the time to attend and really enjoyed sharing my thoughts."
BMS
Director, Manufacturing Technology, Ireland
Registration
Select the relevant ticket for your organisation.
*Delegate tickets must be purchased under the correct classification.
Biopharma tickets are strictly reserved for professionals employed by pharmaceutical or biopharmaceutical companies that develop, own, or commercialise therapeutic drug products, including organisations with an internal drug pipeline spanning discovery, development, clinical, or commercial stages. This category applies to companies whose primary business is the development or manufacture of drug products, not the provision of enabling technologies, equipment, platforms, or services.
Service, Solution, and Technology Provider tickets apply to all organisations offering services, platforms, technologies, equipment, consultancy, manufacturing services, or commercial solutions to the pharma and biopharma industry. This includes, but is not limited to, CROs, CDMOs, technology and equipment vendors, consultants, suppliers, and solution providers, regardless of scientific or technical focus.
Important Notice
All registrations are reviewed to ensure correct classification. Purchasing an incorrect ticket does not guarantee entry to the event. IMAPAC retains full discretion to deny access, reclassify registrations, and issue an invoice for the price difference required for correct attendance. Incorrect ticket purchases made under an inappropriate classification are not eligible for refunds under any circumstances, including where the registrant chooses not to upgrade or attend.
Registration
Register Your Interest
Be the first in line!
Register your interest to get access to tickets as soon as they go live.
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Pre Conference Workshops & Other Sessions
Visit the event page to view more content.
No items found.
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organisations.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.